Bioventus Inc. reported $138.964 million in sales and $4.074 million in operating profit for the quarter ending September 30, 2024, which met both Wall Street’s expectations and management’s guidance.
Company News Premium
Bioventus Grows Sales Significantly in Q3, 2024
1 min read Premium comments

Premium#bioventus#3q24earnings
React:
